Companies / Addex Therapeutics Ltd.
Addex Therapeutics Ltd.
Nasdaq: ADXNForeign · IFRSCIK 1574232GENEVA
Financials · FY2024 · CHF
Ownership
147.8M shares outstanding
Ownership
| Institutions | <0.01% | 610 |
| Public float | 100.00% | 147,831,204 |
% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 8
View all →| Insider | % of shares | Shares |
|---|---|---|
Dyer Timothy MarkCEOChief Executive Officer · Director · 10% owner | — | — |
Hill Raymond GeorgeDirector | — | — |
Kalinichev MikhailHEAD OF TRANSLATIONAL SCIENCE | — | — |
Lawton Vincent MichaelDirector | — | — |
Manke IsaacDirector | — | — |
Mills RogerCHIEF MEDICAL OFFICER · Director | — | — |
Nunn Jason RaleighDirector | — | — |
Teyssedou Lenaic NathanaelPRINCIPAL ACCOUNTING OFFICER | — | — |
Institutional holders 5
View all →| Holder | Value | % of shares |
|---|---|---|
| $2.3K | <0.01% | |
| $1.2K | <0.01% | |
| $625 | <0.01% | |
| $450 | <0.01% | |
| $8 | <0.01% |
Activity
Mar 31, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).No activity matches these filters.
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ADXN | ADR | 00654J206 |